| Literature DB >> 3061823 |
R Labianca1, G Pancera, B Cesana, M Clerici, F Montinari, G Luporini.
Abstract
Sixty patients with advanced colorectal cancer were randomized between cisplatin (60 mg/mq i.v. every 3 weeks) + 5-fluorouracil (600 mg/mq i.v. bolus/weekly) and 5-fluorouracil alone (same schedule). In the 54 evaluable patients, no CR was observed. PR rate was 19.2% for the combination, and 14.5% for the monochemotherapy. Also the overall median survival time was similar for the two arms (10 and 13 months, respectively). Toxicity was acceptable, with more side-effects in the combination arm. Both treatments are of limited activity in advanced colorectal cancer and no advantage comes out from the use of this polychemotherapy.Entities:
Mesh：
Substances：
Year: 1988 PMID： 3061823 DOI： 10.1016/0277-5379(88)90048-x
Source DB: PubMed Journal: Eur J Cancer Clin Oncol ISSN： 0277-5379